A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.
Researchers at Vaxart Inc. and the Center for Vaccine Development at the University of Maryland School of Medicine evaluated ...
Serum IgA and IgG responses remained elevated above ... Oral administration of VXA-G1.1-NN was found to be safe, well tolerated, and capable of generating durable immune responses in older adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback